PREVIOUS ISSUE NEXT ISSUE
October 2016 OT101516_Cover.jpg
Exploring anti-VEGF therapy for orbital vascular lesionsFindings from immunohistochemical analysis of vascular endothelial growth factor (VEGF) receptor expression on pathology specimens of orbital vascular tumors suggest a potential therapeutic role for anti-VEGF agents.
Endoscopy can aid treatment of pediatric nasolacrimal duct obstructionUsing an endoscope allows the clinician to visualize the tip of the probe and remove a pediatric nasolacrimal duct obstruction more easily, quickly, and accurately.
AD-IOLs mimic movement of natural lensAccommodating-disaccommodating IOLs are being developed that mimic the movement of the young crystalline lens through the use of “Zonular Capture Haptics” technology.
Surgeons face choices in pediatric orbital cellulitisWhen treating cases of pediatric orbital cellulitis, it is essential that clinicians consider the risks and advantages of antibiotics, steroids, and surgery.
Targeting refractory vitreous seeds in retinoblastomaA retrospective study reviewing outcomes of 17 consecutive eyes with retinoblastoma treated for refractory vitreous seeds found intravitreal topotecan was safe and resulted in complete regression in all eyes after a mean of three injections.
Orbital surgery aided by 3-D printingPreoperative computer-assisted manipulation of CT images—with 3-D printing of anatomic models and intraoperative guides—can be a powerful tool in managing complex periorbital fractures, explains Paul Langer, MD.
No-stitch blepharoplasty: Revisiting use of tissue adhesiveTissue adhesive has a place in blepharoplasty but the caveat is that patient selection is extremely important.
ARVO 2017 making global connections in vision researchThough the year is quickly winding down, clinical education opportunities still abound for clinicians and vision researchers via the Association for Research in Vision and Ophthalmology (ARVO). For instance, a one-day public workshop will focus on the newest clinical data on inherited retinal diseases and future clinical trial designs aimed at developing therapies to stem vision loss.
Exploring surgical solution for recalcitrant neurotrophic keratopathyA team of ophthalmic surgeons describes successful corneal neurotization using an ipsilateral supraorbital nerve in a patient with recalcitrant neurotrophic keratopathy
Simultaneous ocular myasthenia gravis and thyroid eye disease: bewareThyroid eye disease (TED) is an autoimmune disease that is usually seen in patients with Graves’ thyrotoxicosis although it can also be seen in hypothyroid as well as euthyroid patients. Myasthenia gravis (MG) is also an autoimmune antibody mediated disorder characterized by fluctuating weakness of the skeletal muscles that can occur with TED.
PREVIOUS ISSUE NEXT ISSUE